Поиск

Ann Jane добавлена новая статья Technology
2024-09-27 01:30:11

Revolutionizing Cancer Research: CD BioSciences Debuts Centrosome Antibody Development Services
CD BioSciences has launched centrosome antibody development services for cancer research CD BioSciences, a biotech company specializing in centrosomal study, has recently launched new services for anti-centrosome antibody development. The services help identify and track centrosomes in experiments, demonstrating the strength of anti-centrosome antibodies as a great tool for...

0 Комментарии 0 Поделились 21066 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Becky Davis добавлена новая статья Другое
2026-01-28 06:12:35

A Complete Guide for Antibody Drug Conjugate Manufacturing
ADC manufacturing is an emerging and highly complex biopharmaceutical technology that has attracted significant attention from innovative biopharmaceutical companies and CDMO procurement professionals. Antibody–drug conjugates (ADCs) are a class of precision therapeutics in which highly potent small-molecule cytotoxic drugs are chemically linked to tumor-targeting antibodies. The design...

0 Комментарии 0 Поделились 960 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Jason Dengyuemed добавлена новая статья Health
2026-01-19 07:51:20

Akeso’s Ivonescimab (PD-1/VEGF Bispecific Antibody) Submits BLA to the FDA
On January 12, 2026, Summit Therapeutics announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ivonescimab, a PD-1/VEGF bispecific antibody developed by Akeso. The application seeks approval for ivonescimab in combination with chemotherapy as a second-line treatment for patients with locally advanced or metastatic non-squamous...

0 Комментарии 0 Поделились 1086 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Toya Tang добавлена новая статья Technology
2024-12-12 09:13:06

Alfa Cytology Launches Innovative Bladder Cancer Therapeutic Antibody Development Services
Alfa Cytology has unveiled new services focused on therapeutic antibody development for bladder cancer research. Alfa Cytology, a prominent cancer research services supplier based in New York, proudly announces the launch of its comprehensive services for bladder cancer therapeutic antibody development. This initiative represents a critical advancement in pursuing effective bladder...

0 Комментарии 0 Поделились 11520 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Adam Wilson добавлена новая статья Health
2025-01-06 05:12:29

Antibody Development Service
Because of the inaccuracy and low efficiencies of traditional treatment, such as surgery, chemotherapy, and radiotherapy, in recent years, RDC (Radionuclide Drug Conjugate), with targeted diagnosis and imaging, has been widely noticed and studied in recent years. The targeting biomolecules in RDC could be antibodies, small molecules, and peptides, in which antibodies are most commonly used,...

0 Комментарии 0 Поделились 9455 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Nikita Pawar добавлена новая статья Business
2025-11-06 11:36:48

Antibody Drug Conjugate Market Projected to Reach New Heights by 2032
The global antibody drug conjugate (ADC) market is experiencing rapid growth driven by the rising prevalence of cancer, advancements in targeted therapy, and continuous innovation in antibody engineering and cytotoxic payload technologies. Valued at USD 12.70 billion in 2024, the market is projected to expand to USD 14.20 billion in 2025 and further reach USD 35.40 billion by 2032, registering...

0 Комментарии 0 Поделились 1639 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kan Kumar добавлена новая статья SEO
2025-09-07 16:30:30

Antibody Drug Conjugates: A Market Transformation in Cancer Treatment
The global therapeutic sector is witnessing an unprecedented evolution, fueled by revolutionary advances in precision medicine and innovative treatment modalities. At the forefront of oncological breakthroughs stands the remarkable progression of Antibody Drug Conjugates (ADCs)—cutting-edge biopharmaceutical compounds that seamlessly integrate the targeted precision of monoclonal...

0 Комментарии 0 Поделились 3246 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kan Kumar добавлена новая статья SEO
2025-07-25 08:26:52

At the Cutting Edge: 7 Leaders in Trispecific Antibody Research
Trispecific antibodies are rapidly emerging as the next-generation modality in immunotherapy, offering a transformative approach to targeting cancer and other diseases. These engineered molecules can simultaneously interact with three different targets—whether antigens or immune cells—leading to improved specificity and enhanced therapeutic activity, particularly in oncology....

0 Комментарии 0 Поделились 3827 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Gemini Smith добавлена новая статья Health
2026-01-23 07:49:16

Beyond the Y-Shape: Is Your Antibody Fighting with One Hand Tied Behind Its Back?
For decades, the Y-shaped IgG molecule has been the undisputed heavyweight champion of precision medicine. It’s elegant, stable, and remarkably effective. But as we dive deeper into the chaotic microenvironments of refractory cancers and complex autoimmune "cross-talk," a sobering realization has set in: sometimes, two hands aren’t enough. In the high-stakes world of...

0 Комментарии 0 Поделились 934 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Nikita Pawar добавлена новая статья Business
2026-03-05 05:21:09

Bispecific Antibody Market Size Expands as Pharmaceutical Companies Accelerate Research
Bispecific Antibody Market Size, Share, Growth & Industry Analysis, By Indication (Cancer, Inflammatory & Autoimmune Disorder, Others), By Distribution Channel (Hospital, Retail, Drugstores, Online), and Regional Analysis, 2024–2031 The global bispecific antibody market is experiencing remarkable expansion as the biotechnology and pharmaceutical industries...

0 Комментарии 0 Поделились 354 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!

Расширенные страницы

Connect Freelancing Platform